236 related articles for article (PubMed ID: 8140932)
1. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones.
Gronowicz GA; Derome ME
J Bone Miner Res; 1994 Feb; 9(2):193-201. PubMed ID: 8140932
[TBL] [Abstract][Full Text] [Related]
2. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro.
Gronowicz G; McCarthy MB; Raisz LG
J Bone Miner Res; 1990 Dec; 5(12):1223-30. PubMed ID: 2127506
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous assessment of bone resorption and formation in cultures of 22-day fetal rat parietal bones: effects of parathyroid hormone and prostaglandin E2.
Vargas SJ; Raisz LG
Bone; 1990; 11(1):61-5. PubMed ID: 2331433
[TBL] [Abstract][Full Text] [Related]
5. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
6. Ascorbic acid alters collagen integrins in bone culture.
Ganta DR; McCarthy MB; Gronowicz GA
Endocrinology; 1997 Sep; 138(9):3606-12. PubMed ID: 9275042
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
8. Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
King KL; D'Anza JJ; Bodary S; Pitti R; Siegel M; Lazarus RA; Dennis MS; Hammonds RG; Kukreja SC
J Bone Miner Res; 1994 Mar; 9(3):381-7. PubMed ID: 8191932
[TBL] [Abstract][Full Text] [Related]
9. Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.
van der Pluijm G; Most W; van der Wee-Pals L; de Groot H; Papapoulos S; Löwik C
Endocrinology; 1991 Sep; 129(3):1596-604. PubMed ID: 1874190
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies of the s-echistatin inhibition of bone resorption.
Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
[TBL] [Abstract][Full Text] [Related]
11. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
13. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
Dresner-Pollak R; Rosenblatt M
J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
[TBL] [Abstract][Full Text] [Related]
15. In vitro mineralization of fetal rat parietal bones in defined serum-free medium: effect of beta-glycerol phosphate.
Gronowicz G; Woodiel FN; McCarthy MB; Raisz LG
J Bone Miner Res; 1989 Jun; 4(3):313-24. PubMed ID: 2763870
[TBL] [Abstract][Full Text] [Related]
16. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
Horton MA; Taylor ML; Arnett TR; Helfrich MH
Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture.
Chen TL; Bates RL
J Bone Miner Res; 1993 Apr; 8(4):423-34. PubMed ID: 8475792
[TBL] [Abstract][Full Text] [Related]
18. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.
Sone T; Kohno H; Kikuchi H; Ikeda T; Kasai R; Kikuchi Y; Takeuchi R; Konishi J; Shigeno C
Endocrinology; 1992 Dec; 131(6):2742-6. PubMed ID: 1306984
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture.
Pilbeam CC; Alander CB; Simmons HA; Raisz LG
Bone; 1993; 14(5):717-20. PubMed ID: 8268045
[TBL] [Abstract][Full Text] [Related]
20. Morphology of osteoclasts in resorbing fetal rat bone explants: effects of PTH and AIF in vitro.
Wezeman FH; Kuettner KE; Horton JE
Anat Rec; 1979 Jul; 194(3):311-23. PubMed ID: 224732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
